» Articles » PMID: 34834196

Ultrasound and Microbubbles for the Treatment of Ocular Diseases: From Preclinical Research Towards Clinical Application

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2021 Nov 27
PMID 34834196
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The unique anatomy of the eye and the presence of various biological barriers make efficacious ocular drug delivery challenging, particularly in the treatment of posterior eye diseases. This review focuses on the combination of ultrasound and microbubbles (USMB) as a minimally invasive method to improve the efficacy and targeting of ocular drug delivery. An extensive overview is given of the in vitro and in vivo studies investigating the mechanical effects of ultrasound-driven microbubbles aiming to: (i) temporarily disrupt the blood-retina barrier in order to enhance the delivery of systemically administered drugs into the eye, (ii) induce intracellular uptake of anticancer drugs and macromolecules and (iii) achieve targeted delivery of genes, for the treatment of ocular malignancies and degenerative diseases. Finally, the safety and tolerability aspects of USMB, essential for the translation of USMB to the clinic, are discussed.

Citing Articles

Controlled Release of Molecules to Enhance Cell Survival and Regeneration.

Fan X, Harding P, DiLeo M Methods Mol Biol. 2024; 2848:259-267.

PMID: 39240528 DOI: 10.1007/978-1-0716-4087-6_16.


Sonodynamic effect based on vancomycin-loaded microbubbles or meropenem-loaded microbubbles enhances elimination of different biofilms and bactericidal efficacy.

Yao L, Chu C, Li Y, Cao L, Yang J, Mu W Bone Joint Res. 2024; 13(9):441-451.

PMID: 39222931 PMC: 11368542. DOI: 10.1302/2046-3758.139.BJR-2023-0319.R3.


Focused Ultrasound as a Novel Non-Invasive Method for the Delivery of Gold Nanoparticles to Retinal Ganglion Cells.

Park Y, Shin J, Park J, Kim S, Park J, Kim J Transl Vis Sci Technol. 2024; 13(5):5.

PMID: 38713474 PMC: 11086706. DOI: 10.1167/tvst.13.5.5.


An Update on Strategies to Deliver Protein and Peptide Drugs to the Eye.

Boddu S, Acharya D, Hala V, Jani H, Pande S, Patel C ACS Omega. 2023; 8(39):35470-35498.

PMID: 37810716 PMC: 10552503. DOI: 10.1021/acsomega.3c02897.


Ultrasound-Mediated Ocular Drug Delivery: From Physics and Instrumentation to Future Directions.

Duncan B, Al-Kassas R, Zhang G, Hughes D, Qiu Y Micromachines (Basel). 2023; 14(8).

PMID: 37630111 PMC: 10456754. DOI: 10.3390/mi14081575.


References
1.
Mohamed Q, Gillies M, Wong T . Management of diabetic retinopathy: a systematic review. JAMA. 2007; 298(8):902-16. DOI: 10.1001/jama.298.8.902. View

2.
Walia A, Yang J, Huang Y, Rosenblatt M, Chang J, Azar D . Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications. Biochim Biophys Acta. 2015; 1850(12):2422-38. PMC: 4624607. DOI: 10.1016/j.bbagen.2015.09.007. View

3.
Del Amo E, Rimpela A, Heikkinen E, Kari O, Ramsay E, Lajunen T . Pharmacokinetic aspects of retinal drug delivery. Prog Retin Eye Res. 2016; 57:134-185. DOI: 10.1016/j.preteyeres.2016.12.001. View

4.
Giblin M, Shields J, Shields C, Eagle Jr R . Primary eyelid malignant melanoma associated with primary conjunctival malignant melanoma. Aust N Z J Ophthalmol. 1988; 16(2):127-31. DOI: 10.1111/j.1442-9071.1988.tb01261.x. View

5.
Li W, Liu S, Ren J, Xiong H, Yan X, Wang Z . Gene transfection to retinal ganglion cells mediated by ultrasound microbubbles in vitro. Acad Radiol. 2009; 16(9):1086-94. DOI: 10.1016/j.acra.2009.03.019. View